Google+ Facebook Twitter Twitter

Blood cell production insights

A healthy adult makes about two million blood cells every second, and 99% of them are oxygen-carrying red blood cells. 


The remaining one percent are platelets and the various white blood cells of the immune system.

How all the different kinds of mature blood cells are derived from the same “haematopoietic” stem cells in the bone marrow has been the subject of intense research over recent years.

However, most of the studies have focused on the one percent – the immune cells.

Camilla Forsberg, a Professor of Biomolecular Engineering, said: “It is a bit odd, but because red blood cells are enucleated and therefore hard to track by genetic markers, their production has been more or less ignored by the vast number of studies in the past couple of decades.”

Her team overcame technical obstacles to provide a thorough accounting of blood cell production from haematopoietic stem cells.

They state that their work is important for understanding disorders, such as anaemia, diseases of the immune system, and blood cancers, such as leukaemias and lymphomas.

One key finding is that all progenitor cells with myeloid potential are able to produce far more red blood cells than any other cell type.

This was surprising because many previous studies in which progenitor cells were grown in vitro found that they had limited capacity to produce red blood cells and platelets. Forsberg said those results now appear to be an artefact of the culture conditions.  

Find out more, here.

Image credit | iStock

Related Articles


Blood test for pregnant women

A new blood test to check for the potentially life-threatening condition pre-eclampsia will be available to women in England.

Blood test for rare cancer proteins

A new blood test developed at the Johns Hopkins University can identify individual molecules in human blood samples with minimal detection errors. 

Blood clot discovery

Scientists have discovered new ways in which the body regulates blood clots, which could lead to the development of better treatments to help prevent and treat conditions including heart diseases, stroke and vascular dementia.

Detecting atrial fibrillation

Could routine screening for atrial fibrillation be in the pipeline? Jonathan Mant is leading the programme that he hopes will be the catalyst.